Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BAYER AS
AS
Active
Org 911268647
Drammensveien 288, 0283
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1964 · 61 years old
129 employees
www.bayer.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BAYER AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
AB
Axel Berg-Larsen
Deputy Member
Deputy Member
2023
GT
Gørild Thuen Jensen
Deputy Member
Deputy Member
2023
MG
Milosz Grzegorz Rolinski
Deputy Member
Deputy Member
2023
Former (4)
GF
Gjermund Fjeld Olsen
Deputy Member
Deputy Member
2022 – 2023
JB
Jan Børge Jakobsen
Chief Executive Officer
Chief Executive Officer
2018 – 2024
AG
Alex Gordon Papple
Deputy Member
Deputy Member
2022 – 2023
SM
Siri Mangschou
Deputy Member
Deputy Member
2019 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
TA
Therese Andersen
Board of Directors
Board of Directors
2023
EH
Erik Helstad
Chairman
Chairman
2025
AS
Ann-Christin Siltvedt
Board of Directors
Board of Directors
2022
TB
Thomas Birger Edén-Jensen
Board of Directors
Board of Directors
2025
GS
Gro Salberg
Board of Directors
Board of Directors
2023
AS
Anita Sollie
Board of Directors
Board of Directors
2025
Former (7)
BK
Bente Kristin Sæten
Board of Directors
Board of Directors
2022 – 2023
CE
Christine Ellingsen
Board of Directors
Board of Directors
2019 – 2022
JK
Johanna Kristiina Kouru
Board of Directors
Board of Directors
2022 – 2023
TE
Thor Even Skotgård
Board of Directors
Board of Directors
2022 – 2023
CT
Christiane Temminghoff
Chairman
Chairman
2022 – 2025
AK
Anna Karolina Svahn
Board of Directors
Board of Directors
2022 – 2025
MH
Miriam Holstein
Chairman
Chairman
2019 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Bayer Norway As
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BAYER AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network